D C Tormey - Concepedia

Author

D C Tormey

University of Wisconsin–Madison

Also Known As

D C Tormey, D TORMEY, D Tormey, D. C. TORMEY, D. C. Tormey, D. Tormey, DOUGLASS C. TORMEY, Daniel Tormey

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Wisconsin–Madison University of Wisconsin Carbone Cancer Center The University of Texas Health Science Center at San Antonio Dana-Farber Cancer Institute University of Pretoria

About

D C Tormey is an author at University of Wisconsin–Madison specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	29	2.8K
2	Health Sciences	6	6	1.1K
3	Cell Biology	2	2	150
4	Nursing	1	1	53
5	Allergy	1	1	102

D C Tormey

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. D. Craig Allred, Gary M. Clark, Amol Tandon, Journal of Clinical Oncology	1992	458
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. Thomas J. Saphner, D C Tormey, Richard Gray Journal of Clinical Oncology Surgical OncologyBreast OncologyPremenopausal PatientsPharmacotherapyAdjuvant Therapy	1991	402
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. C G Moertel, Thomas R. Fleming, J. S. Macdonald, Journal of Clinical Oncology	1995	374
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. Philip Bonomi, Dianne M. Finkelstein, John C. Ruckdeschel, Journal of Clinical Oncology Combination ChemotherapyHealth SciencesMedicineFirst-line MvpMetronomic Therapy	1989	323
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. Barbara Fowble, Robert J. Gray, Kennedy W. Gilchrist, Journal of Clinical Oncology Surgical OncologyBreast OncologyRadiation TherapyMedicineAdjuvant Chemotherapy	1988	205
Alteration of Endocrine Parameters in Premenopausal Women With Breast Cancer During Long-Term Adjuvant Therapy With Tamoxifen as the Single Agent V. Craig Jordan, Nancy F. Fritz, Susan M. Langan-Fahey, JNCI Journal of the National Cancer Institute Breast OncologyGynecologyMenopausal Hormone TherapyEndocrine ParametersFemale Reproductive Function	1991	152
Steroid hormone receptors in normal human lymphocytes. Induction of glucocorticoid receptor activity by phytohemagglutinin stimulation. James P. Neifeld, Marc E. Lippman, D C Tormey Journal of Biological Chemistry Glucocorticoid Receptor ActivityEndocrine MechanismSteroid Hormone ReceptorsNormal Human LymphocytesPhysiology	1977	132
Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal Cancer Richard M. Hansen, Louise Ryan, Tom Anderson, JNCI Journal of the National Cancer Institute	1996	130
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. P. Ravdin, Nancy F. Fritz, D C Tormey, PubMed Hormonal ContraceptiveLong-term TamoxifenBreast OncologyEndocrine OncologyMedicine	1988	122
Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. V. Craig Jordan, Nancy F. Fritz, D C Tormey PubMed Hormonal ContraceptiveBreast OncologyGynecologyPharmacotherapyAdjuvant Tamoxifen Therapy	1987	119

Page 1